Sfoglia per Rivista
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease
2016-01-01 Ferrero, E; Corti, A; Haroche, J; Belloni, D; Colombo, B; Berti, A; Cavalli, G; Campochiaro, C; Villa, A; Cohen-Aubart, F; Amoura, Z; Doglioni, C; Dagna, L; Ferrarini, M
Tocilizumab in patients with multisystem Erdheim-Chester disease
2017-01-01 Berti, A; Cavalli, G; Guglielmi, B; Biavasco, R; Campochiaro, C; Tomelleri, A; Nicoletti, R; Panzacchi, A; Ferrarini, M; Dagna, L
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy
2020-01-01 Daillère, Romain; Derosa, Lisa; Bonvalet, Mélodie; Segata, Nicola; Routy, Bertrand; Gariboldi, Manuela; Budinská, Eva; De Vries, I Jolanda M; Naccarati, Alessio Gordon; Zitvogel, Valérie; Caldas, Carlos; Engstrand, Lars; Loilbl, Sibylle; Fieschi, Jacques; Heinzerling, Lucie; Kroemer, Guido; Zitvogel, Laurence
Titolo | Anno di pubblicazione | Autori Unitn | File |
---|---|---|---|
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease | 1-gen-2016 | Berti A + | |
Tocilizumab in patients with multisystem Erdheim-Chester disease | 1-gen-2017 | Berti A + | |
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy | 1-gen-2020 | Segata, Nicola + |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile